UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-40737
AFTERNEXT HEALTHTECH ACQUISITION CORP.
(Exact name of registrant as specified in its charter)
301 Commerce Street, Suite 3300
Fort Worth, TX
(212) 405-8458
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Units, each consisting of one share of Class A Ordinary Shares and one-third of one Warrant Class A
Ordinary Shares, par value $0.0001 per share
Warrants, each whole warrant exercisable for one share of Class A Ordinary Shares at an exercise price of $11.50
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| | |
Rule 12g-4(a)(1) | | ☒ |
Rule 12g-4(a)(2) | | ☐ |
Rule 12h-3(b)(1)(i) | | ☒ |
Rule 12h-3(b)(1)(ii) | | ☐ |
Rule 15d-6 | | ☐ |
Rule 15d-22(b) | | ☐ |
Approximate number of holders of record as of the certification or notice date: None